Molecular Resistance Testing Shaping Therapeutics in the Helicobacter pylori Infections Treatment Market
Integrating rapid molecular diagnostic assays and real-time PCR testing is transforming treatment paradigms across the Helicobacter pylori Infections Treatment Market. Molecular stool PCR panels detect specific 23S rRNA point mutations responsible for clarithromycin resistance directly from non-invasive samples, allowing clinicians to prescribe tailored antibiotic combinations during initial...
0 التعليقات 0 المشاركات 210 مشاهدة 0 معاينة